These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 22687488)

  • 21. Nanocrystalline hydroxyapatite: micelle templated synthesis and characterization.
    Wu Y; Bose S
    Langmuir; 2005 Apr; 21(8):3232-4. PubMed ID: 15807558
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of dicalcium phosphate dihydrate cements prepared using a novel hydroxyapatite-based formulation.
    Alge DL; Santa Cruz G; Goebel WS; Chu TM
    Biomed Mater; 2009 Apr; 4(2):025016. PubMed ID: 19349655
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Precipitation and phase transformation of dicalcium phosphate dihydrate in electrolyte solutions of simulated body fluids: Thermodynamic modeling and kinetic studies.
    Rabadjieva D; Sezanova K; Gergulova R; Titorenkova R; Tepavitcharova S
    J Biomed Mater Res A; 2020 Aug; 108(8):1607-1616. PubMed ID: 32180332
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Formation and transformation of calcium phosphate phases under biologically relevant conditions: Experiments and modelling.
    Carino A; Ludwig C; Cervellino A; Müller E; Testino A
    Acta Biomater; 2018 Jul; 74():478-488. PubMed ID: 29778896
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design of surface-modified poly(D,L-lactide-co-glycolide) nanoparticles for targeted drug delivery to bone.
    Choi SW; Kim JH
    J Control Release; 2007 Sep; 122(1):24-30. PubMed ID: 17628158
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In situ fabrication of alendronate-loaded calcium phosphate microspheres: controlled release for inhibition of osteoclastogenesis.
    Kim CW; Yun YP; Lee HJ; Hwang YS; Kwon IK; Lee SC
    J Control Release; 2010 Oct; 147(1):45-53. PubMed ID: 20600398
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Solid titration of octacalcium phosphate.
    Pan HB; Darvell BW
    Caries Res; 2009; 43(4):322-30. PubMed ID: 19556792
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interaction between a bisphosphonate, tiludronate and nanocrystalline apatite: in vitro viability and proliferation of HOP and HBMSC cells.
    Pascaud P; Bareille R; Bourget C; Amédée J; Rey C; Sarda S
    Biomed Mater; 2012 Oct; 7(5):054108. PubMed ID: 22972389
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel insights into actions of bisphosphonates on bone: differences in interactions with hydroxyapatite.
    Nancollas GH; Tang R; Phipps RJ; Henneman Z; Gulde S; Wu W; Mangood A; Russell RG; Ebetino FH
    Bone; 2006 May; 38(5):617-27. PubMed ID: 16046206
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of citrate and NaCl on size, morphology, crystallinity and microstructure of calcium phosphates obtained from aqueous solutions at acidic or near-neutral pH.
    Mekmene O; Rouillon T; Quillard S; Pilet P; Bouler JM; Pezennec S; Gaucheron F
    J Dairy Res; 2012 May; 79(2):238-48. PubMed ID: 22559064
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interaction of acidic poly-amino acids with octacalcium phosphate.
    Bigi A; Boanini E; Bracci B; Falini G; Rubini K
    J Inorg Biochem; 2003 Jul; 95(4):291-6. PubMed ID: 12818799
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bisphosphonates: the first 40 years.
    Russell RG
    Bone; 2011 Jul; 49(1):2-19. PubMed ID: 21555003
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Solid-state NMR study of the transformation of octacalcium phosphate to hydroxyapatite: a mechanistic model for central dark line formation.
    Tseng YH; Mou CY; Chan JC
    J Am Chem Soc; 2006 May; 128(21):6909-18. PubMed ID: 16719471
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo comparison of bone formation on titanium implant surfaces coated with biomimetically deposited calcium phosphate or electrochemically deposited hydroxyapatite.
    Yang GL; He FM; Song E; Hu JA; Wang XX; Zhao SF
    Int J Oral Maxillofac Implants; 2010; 25(4):669-80. PubMed ID: 20657861
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hydroxyapatite as a carrier for bone morphogenetic protein.
    Rohanizadeh R; Chung K
    J Oral Implantol; 2011 Dec; 37(6):659-72. PubMed ID: 20662667
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structural, morphological and surface characteristics of two types of octacalcium phosphate-derived fluoride-containing apatitic calcium phosphates.
    Shiwaku Y; Anada T; Yamazaki H; Honda Y; Morimoto S; Sasaki K; Suzuki O
    Acta Biomater; 2012 Dec; 8(12):4417-25. PubMed ID: 22868193
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sol-gel derived titania coating with immobilized bisphosphonate enhances screw fixation in rat tibia.
    Linderbäck P; Areva S; Aspenberg P; Tengvall P
    J Biomed Mater Res A; 2010 Aug; 94(2):389-95. PubMed ID: 20186735
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Underlying Role of Brushite in Pathological Mineralization of Hydroxyapatite.
    Zhang J; Wang L; Putnis CV
    J Phys Chem B; 2019 Apr; 123(13):2874-2881. PubMed ID: 30840456
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis of dental enamel-like hydroxyapatite through solution mediated solid-state conversion.
    Zhang J; Jiang D; Zhang J; Lin Q; Huang Z
    Langmuir; 2010 Mar; 26(5):2989-94. PubMed ID: 20112925
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bisphosphonates do not inhibit periosteal bone formation in estrogen deficient animals and allow enhanced bone modeling in response to mechanical loading.
    Feher A; Koivunemi A; Koivunemi M; Fuchs RK; Burr DB; Phipps RJ; Reinwald S; Allen MR
    Bone; 2010 Jan; 46(1):203-7. PubMed ID: 19857619
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.